Table 2.
Biomarker medians (25th, 75th percentile) by group over time*
Day +7 | Day +14 | Day +21 | Day +30 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
aGVHD+ | No aGVHD |
C- stat |
p- value |
aGVHD+ | No aGVHD |
C- stat |
p- value |
aGVHD+ | No aGVHD |
C- stat |
p- value |
aGVHD+ | No aGVHD |
C- stat |
p- value |
|
ST2 ng/ml | 73.2 (25.9, 149.2) | 25.7 (12.9, 42.7) | 0.72 | 0.03 | 53.8 (26.8, 95.9) | 19.8 (14.4, 42.3) | 0.74 | 0.02 | 28.3 (18.8, 143.9) | 16.2 (12.5, 23.7) | 0.75 | 0.02 | 26.3 (10.3, 134.4) | 15.0 (11.2, 22.0) | 0.68 | 0.09 |
Reg3α pg/ml | 51.4 (24.2, 93.5) | 40.5 (20.0, 53.2) | 0.63 | 0.20 | 194.8 (46.7, 825.0) | 50.3 (23.6, 72.9) | 0.73 | 0.03 | 178.1 (54.0, 649.5) | 41.7 (29.6, 64.6) | 0.76 | 0.01 | 130.6 (52.5, 605.2) | 51.4 (30.1, 87.8) | 0.73 | 0.03 |
Elafin pg/ml | 7628.3 (4303.0, 18557.2) | 5088.0 (3530.3, 8057.8) | 0.62 | 0.26 | 10156.8 (5531.0, 14428.2) | 4610.0 (3416.2, 8140.6) | 0.71 | 0.04 | 7793.0 (4610.0, 10586.5) | 5931.4 (3916.6, 10941.0) | 0.54 | 0.74 | 6987.6 (5355.0, 12224.5) | 8794.1 (5786.9, 15783.8) | 0.57 | 0.45 |
TNFR1 pg/ml | 4348.9 (2408.7, 6562.1) | 3747.1 (2025.1, 4341.2) | 0.62 | 0.23 | 5695.1 (2946.4, 9701.1) | 3809.8 (2391.9, 4935.8) | 0.64 | 0.20 | 5443.2 (3974.0, 6784.1) | 4528.0 (2692.6, 5492.5) | 0.67 | 0.11 | 4421.9 (3261.4, 7989.6) | 4094.6 (3150.5, 5572.2) | 0.49 | 0.33 |
sIL2Rα (pg/ml | 883.2 (254.6, 1673.0) | 137.5 (50.1, 481.0) | 0.70 | 0.14 | 269.1 (26.1, 3051.3) | 95.7 (83.8, 265.3) | 0.61 | 0.41 | 930.5 (194.3, 2098.1) | 216.6 (167.4, 398.1) | 0.68 | 0.13 |
For ST2, Reg3α, Elafin, and TNFR1, sample sizes were 17, 16, 17, and 16 for GVHD+ and 17, 15, 15, and 16 for GVHD- for Day +7, +14, +21, and +30 respectively. For sIL2Rα, sample sizes were 12, 10, and 10 for GVHD+ and 10, 13, and 14 for GVHD- for Day +7, +14, and +21 respectively.